Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStar Energy Regulatory News (STAR)

Share Price Information for Star Energy (STAR)

Share Price is delayed by 15 minutes
Get Live Data
19.00    0.40 (2.11%)
Bid:
18.00
Ask:
20.00
Spread: 2.00 (11.111%)
Market Cap: £37.37m
STAR Live PriceLast checked at - London Stock Exchange

Intraday Star Energy Share Chart

Issue of Equity

18 Apr 2019 07:00

RNS Number : 5557W
Starcom PLC
18 April 2019
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). In addition, market soundings were taken in respect of the matters contained in this announcement, with the result that certain persons became aware of such inside information. Upon the publication of this announcement, this inside information is now considered to be in the public domain and such persons shall therefore no longer in possession of inside information relating to the Company and its securities. 

 

18 April 2019

 

Starcom Plc

("Starcom" or the "Company")

 

Issue of equity

 

Starcom (AIM: STAR), which specialises in the development of wireless solutions for the remote tracking, monitoring and protection of a variety of assets, is pleased to announce that the Company has conditionally raised £637,500 before expenses through a subscription of 51,000,000 new Ordinary Shares of no par value (the "Subscription Shares") at a price of 1.25 pence per Subscription Share, (the "Subscription"). The Subscription is being undertaken utilising the Company's existing share authorities and has been subscribed for by a combination of new and existing shareholders. 

 

The net proceeds of the Subscription will be used to pay suppliers in order to satisfy further demand for the Company's products, including the new Lokies padlock, details of which were announced on 5 April 2019. In addition, the Company intends to use the net proceeds of the Subscription to intensify its marketing and sales effort and for general working capital purposes. The Directors consider that undertaking an equity raise of this size at this stage will place the Company in a better financial position to pursue its strategy and, at the same time, avoid the requirement for more frequent capital raises that it has made in the past.

 

In addition to the Subscription and in an attempt to conserve the Company's cash position, the Directors are proposing to receive Ordinary Shares and/or options in lieu of historic unpaid director salaries and future fees as they fall. The details of these proposals are still to be finalised by the Board and any such proposals would be made subject to shareholder approval at a general meeting of the Company. Further announcements will be made in due course.

 

Proposed board appointment

 

The Company is pleased to announce its intention to appoint Martin Blair as non-executive director of the Company, subject to satisfactory completion of customary due diligence by its nominated adviser, in accordance with the AIM Rules. Martin Blair is a highly experienced director within the software, life sciences and media industries and is currently a director of Kape PLC, Cakebox Holdings plc and Green Biologics Ltd. Further updates will be made in due course.

 

Application for Admission

 

Application has been made for the Subscription Shares, which will rank pari passu with the Company's existing Ordinary Shares, to be admitted to trading on AIM ("Admission"). It is anticipated that Admission will become effective at 8.00 a.m. on 24 April 2019. 

 

Total voting rights 

 

On Admission, the Company's enlarged issued share capital will comprise 344,449,513 Ordinary Shares. The Company does not hold any shares in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company will be 344,449,513. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

Michael Rosenberg, Chairman of Starcom commented, "These new funds will enable the Company to pursue a more aggressive marketing strategy as we are promoting our new range of tracking and monitoring products, to take advantage of the positive responses we are receiving from existing and potential clients and to leverage our position as one of the world leaders in our technological market place."

 

Information for Distributors

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the Product Governance Requirements) may otherwise have with respect thereto, the Subscription Shares have been subject to a product approval process by Allenby Capital Limited, which has determined that the Subscription Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, investors should note that: the price of the Subscription Shares may decline and investors could lose all or part of their investment; Subscription Shares offer no guaranteed income and no capital protection; and an investment in Subscription Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Subscription. Furthermore, it is noted that, notwithstanding the Target Market Assessment, only investors who have met the criteria of professional clients and eligible counterparties have been procured. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to Subscription Shares.

 

-ends-

 

Enquiries:  

 

Starcom Plc

 

Michael Rosenberg, Chairman

07785 727 595

Avi Hartmann, CEO 

+972 5447 5663

 

 

Allenby Capital Limited (Nominated Adviser and Broker)

020 3328 5656

James Reeve / Jeremy Porter / Asha Chotai 

 

 

Peterhouse Capital Limited (Joint Broker)

020 7469 0930

Lucy Williams / Charles Goodfellow / Eran Zucker 

 

 

Leander PR (Financial PR)

07795 168 157

Christian Taylor-Wilkinson

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBRGDSUUBBGCR
Date   Source Headline
28th May 20269:43 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSExercise of Options and Total Voting Rights
21st May 20264:56 pmRNSHolding(s) in Company
21st May 20264:55 pmRNSHolding(s) in Company
21st May 20262:40 pmRNSHolding(s) in Company
21st May 202612:05 pmRNSBlock Listing Application
19th May 202610:46 amRNSHolding(s) in Company
18th May 202612:43 pmRNSResult of General Meeting and Total Voting Rights
7th May 20267:00 amRNSResult of Retail Offer
1st May 20267:01 amRNSProposed Retail Offer to raise up to £0.6 million
1st May 20267:00 amRNSResult of Fundraising and Notice of GM
30th Apr 20264:58 pmRNSLaunch of Placing, Subscription and Retail Offer
30th Apr 20262:53 pmRNSAdditional Listing Director/PDMR Shareholding
29th Apr 20267:00 amRNSHolding(s) in Company
29th Apr 20267:00 amRNSFinal Results
24th Apr 202611:34 amRNSSale of Croatian geothermal company
8th Apr 20262:35 pmRNSHolding(s) in Company
25th Feb 20267:00 amRNSTrading Update
29th Jan 20267:00 amRNSAdditional Listing Director/PDMR Shareholding
19th Dec 20259:57 amRNSBlock Listing Six Monthly Return
19th Dec 20259:57 amRNSBlock Listing Six Monthly Return
8th Dec 20252:30 pmRNSTotal Voting Rights
5th Dec 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
17th Nov 202510:50 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSAdditional Listing Director / PDMR Shareholding
22nd Sep 202511:18 amRNSHolding(s) in Company
19th Sep 20254:37 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
16th Sep 20257:00 amRNSHalf-year Report
5th Aug 20257:00 amRNSAdditional Listing Director/PDMR Shareholding
23rd Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
20th Jun 20257:00 amRNSBlock Listing Six Monthly Return
19th Jun 202512:29 pmRNSResult of AGM
19th Jun 20257:00 amRNS2025 Annual General Meeting Trading Update
10th Jun 20257:00 amRNSTotal Voting Rights
3rd Jun 20251:02 pmRNSForm 8.3 - Dowlais Group plc
3rd Jun 20251:00 pmRNSForm 8.3 - Qualcomm Incorporated
21st May 20251:16 pmRNSAnnual Report & Notice of Annual General Meeting
16th May 20257:00 amRNSGrant of Awards under Management Retention Plan
6th May 20257:00 amRNSPartnership with Veolia - Geothermal Projects
2nd May 20257:00 amRNSAdditional Listing Director/PDMR Shareholding
29th Apr 20257:00 amRNSFinal Results
22nd Apr 20256:00 pmRNSCompletion of Sale of Non-core Asset
8th Apr 20254:22 pmRNS-RReserves & Resources Update
31st Mar 20257:00 amRNS-RMoU with Bring Energy
6th Mar 20257:00 amRNSGrant of Awards
28th Feb 20252:11 pmRNS-RInvestor Presentation
24th Feb 20257:00 amRNSTrading Update
5th Feb 20257:00 amRNSTotal Voting Rights
30th Jan 20257:00 amRNSAdditional Listing Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.